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Research
Correspondence Histopathological Features of Delayed Enhancement
Cardiovascular Magnetic Resonance in
Isolated Left Ventricular NoncompactionTo the Editor: Contrast-enhanced magnetic resonance imaging
(CE-MRI) is an important imaging modality for the evaluation of
isolated left ventricular noncompaction (LVNC). The delayed
gadolinium enhancement has been identified in both compacted
and noncompacted myocardium, and it may correlate with the
clinical severity of LVNC (1–3). However, little is known about
the histological basis of myocardial delayed enhancement in
LVNC patients, especially in the noncompacted myocardium. In
this study, we made a comparison between the myocardial delayed
enhancement and histological findings in a patient with LVNC
who underwent heart transplantation.
A 27-year-old man was admitted with exertional dyspnea.
Chest roentgenogram showed cardiomegaly with pulmonary ve-
nous congestion, and the cardiothoracic ratio was 72%. The
LVNC was diagnosed by echocardiography, and the ratio of the
noncompacted to compacted myocardium was 3.2. The left ven-
tricular end-diastolic dimension was 63 mm, and left ventricular
ejection fraction was 18%. Contrast-enhanced MRI was per-
formed, and deep intertrabecular recesses presented in the apical
and lateral wall of the left ventricle. The near-transmural delayed
enhancement occurred in the interventricular septum, and diffuse
enhancement presented in the free wall and the trabecular mesh-
work region of the left ventricle. In addition, CE-MRI detected
the left ventricular thrombus and pericardial and pleural effusions.
One week later, informed consent was obtained, and heart trans-
plantation was carried out. The pathological findings of the
explanted heart were compared with the previous in vivo CE-MRI
(Fig. 1). In the compacted myocardium with delayed enhance-
Figure 1 Comparison of In Vivo CE-MRI and Histological Sections in LVN
(A) Contrast-enhanced magnetic resonance imaging (CE-MRI) in short-axis view de
left ventricular free wall, and the trabecular meshwork region of the left ventricle.
apical segment of the left ventricle demonstrated that fibrosis presented within tra
mucoid degeneration (asterisk) was identified in endocardium. (Masson’s Trichromment, extensive fibrosis was identified and predominantly localized
in the mid-myocardial wall. The collagen volume fraction was
27.9% in the histological section, which came from the region of
near-transmural delayed enhancement in the interventricular sep-
tum. In the noncompacted myocardium with delayed enhance-
ment (the trabecular meshwork region of left ventricle), however,
2 types of pathological findings presented: mucoid degeneration in
the endocardium and fibrosis within the trabeculations. The
collagen volume fraction of trabeculations was 37.4% in the left
ventricular apex and 32.8% in the lateral wall of the left ventricle.
In the myocardial regions without delayed enhancement, there was
no significant increase in the amount of fibrosis. The epicardial
coronary arteries were normal in the patient.
The results of this study demonstrated that fibrosis was identi-
fied histologically in both compacted and noncompacted myocar-
dium. In the compacted myocardium, the regions of delayed
enhancement corresponded well with the focally increased fibrosis.
Furthermore, CE-MRI may overestimate the degree of fibrosis
replacement, as we found in the interventricular septum. In the
noncompacted myocardium, delayed enhancement was associated
with fibrosis within the trabeculations as well as mucoid degener-
ation in the endocardium.
Previous studies have showed that myocardial delayed enhance-
ment presented in patients with LVNC, and it has been proposed
that the regions of delayed enhancement probably reflected the
regions of increased myocardial fibrosis (1,2). Pathological analysis
also demonstrated that fibrosis occurred in the left ventricular
myocardium of LVNC patients (4,5). However, further research
rated that diffuse delayed enhancement occurred in the interventricular septum,
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July 12, 2011:311–5was lacking to assess the histopathological correlation of myocar-
dial delayed enhancement in LVNC. In the present study, our
findings show that the fibrosis is the histological basis in the
delayed enhancement of compacted myocardium; however, it is
still unknown which mechanism plays the leading role in the
delayed enhancement of noncompacted myocardium.
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cardiomyopathy. Heart 2001;86:666–71.Letters to the EditorDiagnostic Criteria for
Percutaneous Coronary
Intervention-Related
Myocardial Infarction
Time for Revision?
A significant increase of cardiac biomarkers after percutaneous
coronary intervention (PCI) is commonplace and is thought to
reflect a clinically significant myocardial injury. According to the
joint European Society of Cardiology/American College of Car-
diology Foundation/American Heart Association/World Heart
Federation task force for the redefinition of myocardial infarction
(MI), increases of cardiac troponins 3 times the 99th percentile
upper reference limit (URL) are designated as percutaneous
coronary intervention (PCI)-related MI (type 4a) (1).
We read with interest the article by Lim et al. (2), who
concluded that creatine kinase-myocardial band (CK-MB) should
be the preferred biomarker when applying the current universal
definition of MI to periprocedural injury, because the arbitrary
limit of 3 times the 99th percentile URL troponin threshold might
be oversensitive and lead to over-diagnosis of MI in as many as
53% of patients (2). A similar conclusion was earlier reached by
Locca et al. (3), who reported a lack of substantial agreement
between the new universal definition and cardiovascular magnetic
resonance for the diagnosis of small-size periprocedural myocardial
damage after complex PCI (3). Although the current definition of
periprocedural injury based on the 3 times the 99th percentile
URL troponin value might, hence, be challenging, especially whenmeta-analysis of 15 studies and 7,578 patients, concluding that
troponin elevation was observed in 28.7% of patients undergoing
PCI, whereas the incidence of PCI-related MI according to the
new definition was 14.5% (4). Most importantly, any level of raised
troponin was associated with an increased risk of the composite of
all-cause death, MI, repeat target vessel PCI, and coronary artery
bypass graft surgery.
Taken together, this evidence suggests that the arbitrary limit of
3 times the 99th percentile URL troponin threshold for diagnosing
periprocedural injury might be urgently revised, because of 1) the
unsatisfactory diagnostic specificity at this low level; and 2) the
potentially inaccurate selection of the reference population for
calculating the URL (5). Therefore, a higher cut-off—such as that
suggested by Lim et al. (i.e., 40 times the 99th percentile)—should
be used for diagnosing periprocedural MI. This enhanced thresh-
old not only displays diagnostic performances comparable to that
of CK-MB, but also overcomes the use of a double-biomarker
approach (i.e., troponin and CK-MB), with a substantial econom-
ical saving. Nevertheless, the current threshold has meaningful
prognostic implications, so that patients with troponin values
between 3 and 40 times the 99th percentile are to be considered at
risk of adverse events and should be managed accordingly.
It is also noteworthy that sample stability is critical for troponin
testing. Wu et al. (6) recently observed variations in troponin I
above the analytical precision cut-off (as measured with a high-
sensitivity assay) in 17% of short-term and 33% of long-term
storage samples, suggesting that measurements are more accurate
when fresh samples are used, suggesting that the definition of the
optimal thresholds for both defining an increased risk of adverse
events and diagnosing MI after periprocedural injury should be
made preferably using fresh samples.
We are actually trapped between the Scylla of the universal
definition of MI and the Charybdis of the prognostic implications
